Sons of the Neon Night ,” a midnight selection, is a disturbingly bad, wildly incoherent Chinese crime action-thriller. Juno ...

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...

Fed officials say debt downgrade complicates inflation outlook, Nvidia CEO discusses China chip ban, JPMorgan’s investor day, ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Dow Jones Top Company Headlines at 5 PM ET: Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million | Jamie ... The move raises privacy concerns as the drugmaker takes control of the genetic data ...

Regeneron Pharmaceuticals announced Monday it plans to purchase human genetics and biotechnology firm 23andMe from bankruptcy ...

The company has signed up to pay $256 million for 23andMe and nearly all of its assets, including its R&D services operations ...

Regeneron develops new medicines and it rang up $3.7 billion in sales for its anti-inflammatory drug Dupixent as a treatment for eczema, asthma and chronic obstructive pulmonary disease, in its latest ...

Regeneron bids for 23andMe for a discounted price of $256 million. The testing firm was once valued at $3.5 billion.

The top bidder in the DNA testing firm's bankruptcy auction, Regeneron vows to prioritize the privacy, security, and ethical ...

Analysts are intrested in these 5 stocks: ( ($MRK) ), ( ($REGN) ), ( ($CLRB) ), ( ($HUMA) ) and ( ($FL) ). Here is a ...

Yesterday afternoon turned out to be quite the treat overall. Despite a few spotty showers, enough breaks of sunshine got through to send temps into the 70s for most, allowing for some solid ...